A Registrational Phase 2 clinical trial has been initiated in Japan for patients with PSMA-positive metastatic castration-resistant prostate ...
GlobalData on MSN
Telix doses first patient in TLX591-Px prostate imaging trial
Up to 105 Japanese men will be enrolled at 11 sites, with data aimed at supporting a future marketing authorisation ...
News Medical on MSN
Study tests combined targeted radiopharmaceuticals and precision radiation for recurrent prostate cancer
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether combining precision radiation with a targeted radioactive therapy drug can ...
—These findings suggest that conventional imaging significantly underestimates the extent of disease in high-risk, biochemically recurrent prostate cancer, potentially impacting treatment decisions ...
Steve, Jim, Andy and Tim Hastings found out they were battling the same disease within 6 months of one another ...
New research suggests that men who take multivitamins after being diagnosed with prostate cancer may have a lower risk of cancer recurrence. In the overall study group, current multivitamin users ...
Patients who reported current multivitamin use had a lower risk of recurrence than patients who had never taken multivitamins. Patients with prostate cancer may have a lower risk of recurrence if they ...
Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...
Men with prostate cancer who get hormone therapy experience hot flashes, where they experience intense and sudden heat and ...
来自MSN
A True Game-Changer in Prostate Cancer: A Simple Genomic Test Can Tell Us Who Needs Hormone ...
If you or a loved one are navigating the journey of prostate cancer, you know that every decision weighs heavily. You’ve likely faced surgery or initial treatments, only to encounter the fear that ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果